Dune Medical Devices, Ltd. today announced the launch of a pivotal clinical trial of the MarginProbe? intraoperative, real-time, positive margin detection system, following U.S. Food and Drug Administration (FDA) investigational device exemption (IDE) approval of its protocol during breast cancer surgery. With the FDA IDE approval in place, Dune is launching a nationwide U.S.
More...